Equity Research Associate

Responsibilities

• Perform deep diligence on biotech platforms including ADCs, oligonucleotides, peptides, and LNP delivery systems
• Evaluate CMC and scale-up risks across development stages, including synthetic routes, formulation, and manufacturing capacity
• Translate technical findings into investment-relevant outputs such as probability-of-success adjustments and margin sensitivities
• Conduct primary research through KOL outreach, expert calls, and proprietary data collection
• Build and maintain company financial models, including forecasting and scenario analysis
• Assist in drafting and publishing research reports, earnings notes, and thematic updates
• Monitor daily news flow, filings, and market developments to propose implications for the Senior Analyst

Requirements

• Master’s degree in Chemical Engineering or a related field with strength in applied chemistry
• 1–3 years of experience in equity research, investment banking, consulting, or biopharma industry roles
• Strong financial aptitude and advanced Excel skills
• Excellent written and verbal communication skills
• Demonstrated interest in Biotechnology and life sciences investing
• Ability to work in a fast-paced, deadline-driven environment

Preferred Qualifications

• Familiarity with biopharma development and regulatory context related to CMC
• Experience with scientific literature review and interpreting clinical datasets
• SIE, Series 63, 86 & 87 licenses

About the Company

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services, operating out of 20 cities worldwide.